Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Suisse (CSUI) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Cannabis Suisse (CSUI) over the last 10 years, with Q4 2025 value amounting to $0.0.

  • Cannabis Suisse's EPS (Weighted Average and Diluted) rose 32074.68% to $0.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $0.0, marking a year-over-year increase of 10535.17%. This contributed to the annual value of -$0.01 for FY2020, which is 240449.89% down from last year.
  • Cannabis Suisse's EPS (Weighted Average and Diluted) amounted to $0.0 in Q4 2025, which was up 32074.68% from $0.0 recorded in Q3 2025.
  • Over the past 5 years, Cannabis Suisse's EPS (Weighted Average and Diluted) peaked at $0.0 during Q1 2025, and registered a low of -$0.01 during Q3 2024.
  • Over the past 5 years, Cannabis Suisse's median EPS (Weighted Average and Diluted) value was -$0.0 (recorded in 2023), while the average stood at -$0.0.
  • Per our database at Business Quant, Cannabis Suisse's EPS (Weighted Average and Diluted) tumbled by 2368.33% in 2021 and then soared by 32074.68% in 2025.
  • Cannabis Suisse's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2021, then skyrocketed by 41.04% to -$0.0 in 2022, then rose by 13.27% to -$0.0 in 2023, then skyrocketed by 102.16% to $0.0 in 2024, then surged by 320.75% to $0.0 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.0 in Q4 2025, compared to $0.0 in Q3 2025 and $0.0 in Q1 2025.